Unlike EGFR in which high expression is associated with poor response to radiation therapy in head and neck cancers [17,18], PD-L1 expression has not been found to correlate with treatment outcomes after radiation therapy for head and neck cancers including NPC. The gene discussed is EGFR; the disease is head and neck cancer.